WO2016159500A1 - Filter for portable peritoneal dialysate regeneration system using enzyme-included silk fibroin and method for manufacturing same - Google Patents

Filter for portable peritoneal dialysate regeneration system using enzyme-included silk fibroin and method for manufacturing same Download PDF

Info

Publication number
WO2016159500A1
WO2016159500A1 PCT/KR2016/000531 KR2016000531W WO2016159500A1 WO 2016159500 A1 WO2016159500 A1 WO 2016159500A1 KR 2016000531 W KR2016000531 W KR 2016000531W WO 2016159500 A1 WO2016159500 A1 WO 2016159500A1
Authority
WO
WIPO (PCT)
Prior art keywords
filter
silk fibroin
peritoneal dialysis
enzyme
activated carbon
Prior art date
Application number
PCT/KR2016/000531
Other languages
French (fr)
Korean (ko)
Inventor
박찬흠
성건용
이옥주
문보미
주형우
이정민
김정호
박현정
김동욱
이민채
김수현
정주연
Original Assignee
한림대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한림대학교 산학협력단 filed Critical 한림대학교 산학협력단
Publication of WO2016159500A1 publication Critical patent/WO2016159500A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1694Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
    • A61M1/1696Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • B01D71/74Natural macromolecular material or derivatives thereof

Definitions

  • the present invention relates to a filter for a portable peritoneal dialysis solution regeneration system, and more particularly, to a filter for a portable peritoneal dialysis solution regeneration system in which an enzyme is encapsulated in silk fibroin or silk protein.
  • the kidney is a biological biological organ that performs the functions necessary to maintain life, and the function of filtering the metabolites in the body and excreted in the urine as well as regulating acid and base equilibrium. Dysfunction of these kidneys builds up waste products in the blood, causing uremia and life threatening. End stage renal failure is permanently reduced in the glomerular filtration function of the kidney is impossible to recover the kidney function is inevitable kidney replacement therapy. Therefore, patients with end-stage renal failure may receive urinary tract disease through transplantation of another person, dialysis of blood through artificial kidneys, or peritoneal dialysis with a glucose solution containing fluid-like components in the peritoneum and exchanged at regular intervals. Remove your back.
  • Kidney transplantation can remove the medium-molecular substances that cannot be removed by dialysis, and can produce hormones such as hematopoietic hormones and can eat and live normally, but the number of organ donors is significantly lower than the number of patients waiting for organ transplantation. to be.
  • the disadvantage is that side effects can occur.
  • Dialysis is known as a safe and effective way to immediately improve symptoms such as volume overload due to kidney failure, hyperkalemia and intoxication by nitrogen waste.
  • Activated carbon is widely used for water purification, and it uses carbonaceous materials such as coconut shell, various woods, lignite, anthracite coal and bituminous coal as raw materials to develop fine pores of molecular size through the activation process. It is characterized by having an internal surface area of more than 1000m 2 per g.
  • Such activated carbon can adsorb low molecular materials and high molecular materials, but it has the selectivity of adsorbing the low molecular materials and then desorbing the small molecules that are adsorbed first and adsorbing the larger molecules when larger molecules come into contact. In order to increase the selectivity, activated carbon may improve the properties for adsorption through acid treatment and the like.
  • the peritoneal dialysis solution of the patient is urea (Calcium), creatinine (Creatinine), glucose (Glucose), phosphorus (Phosphorus), uric acid (Uric acid), albumin (Albumin) and the like.
  • Each component is divided into small molecules, medium molecules, and high molecular materials.
  • Urea 60 Dalton
  • calcium 40 Dalton
  • phosphorus (30 Dalton) belong to low molecular materials
  • uric acid 168 Dalton
  • albumin can be classified as a polymer at 65,000 Dalton.
  • creatinine and uric acid which are medium molecules, can be adsorbed and removed by activated carbon.
  • urea which is a low molecular material, even if initially adsorbed due to adsorption selectivity of activated carbon, Desorption has a disadvantage that does not exhibit a removal effect.
  • Silk is a natural polymer that can be obtained from silkworms. It is a structure in which two strands of fibroin protein are surrounded by sericin protein, and sericin is removed through a process called refining to obtain fibroin protein.
  • Silk fibroin unlike other polymers, does not induce an immune response in the living body and is used for other medical materials such as sutures because it is recognized for safety by the FDA. Due to these advantages, various materials using silk fibroin have been developed one after another.
  • Silk fibroin is a protein extracted from silkworm cocoon, which can be mass-produced and low in cost, and is a polymer that can control the degree of decomposition depending on the production form and crystallization method.
  • the present invention is to improve the quality of life of patients by effectively regenerating the dialysis solution already used by using the enzyme-immobilized silk fibroin and activated carbon filter when patients with end-stage renal failure periodically undergo peritoneal dialysis. have.
  • the present invention provides a filter for regenerating a peritoneal dialysis solution, wherein the enzyme comprises immobilized silk fibroin nanofibers.
  • the enzyme comprises immobilized silk fibroin nanofibers.
  • a polymer is added to the silk fibroin nanofibers, and the polymer is selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like. More preferably.
  • the enzyme may be urease.
  • the silk fibroin nanofibers may further include activated carbon.
  • the present invention also provides a portable peritoneal dialysis solution regeneration system comprising an enzyme-immobilized silk fibroin nanofiber filter layer and an activated carbon filter layer.
  • a portable peritoneal dialysis solution regeneration system comprising an enzyme-immobilized silk fibroin nanofiber filter layer and an activated carbon filter layer.
  • the two filter layers are included in multiple layers.
  • the present invention also provides a method for preparing silk fibroin-polymer-enzyme mixed solution by mixing silk fibroin aqueous solution, polymer and enzyme; Preparing a filter by selecting the mixed aqueous solution from a crowd consisting of electrospinning, electrospraying, and lyophilization; And it provides a method for producing a portable peritoneal dialysis solution regeneration filter comprising the step of insolubilizing the prepared filter.
  • the polymer is preferably at least one selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like.
  • the insolubilization step may recrystallize the filter by selecting one or more of the group consisting of ethanol, methanol, propanol.
  • the insolubilization step may also be treated with water vapor to recrystallize the filter.
  • the step of immobilizing the enzyme to the filter can be performed simultaneously.
  • activated carbon may be further added to form a mixed aqueous solution.
  • the filter according to the present invention can effectively remove the low molecular weight material and very effectively regenerate the peritoneal dialysis solution.
  • it can be used simultaneously with the existing activated carbon filter, more effective dialysis fluid regeneration is possible.
  • the silk fibroin filter according to the present invention has advantages such as mass productivity, controllable degradability, enzyme fixation, and the like, and has an excellent dialysis solution regeneration effect as a filter for a portable peritoneal dialysis solution regeneration system to which an enzyme such as urease is immobilized.
  • 1 is a graph showing the removal rate of the peritoneal dialysis solution according to the change in the stirring time of the peritoneal dialysis solution and activated carbon.
  • Figure 2 is a graph of the removal rate of the peritoneal dialysis solution according to the change in the amount of activated carbon when stirring the peritoneal dialysis solution and activated carbon.
  • Figure 4 is a photograph observing the structure of the silk fibroin filter produced by electrospinning through SEM.
  • 5 is a graph showing the porosity of the silk fibroin filter produced by the electrospinning.
  • Figure 6 illustrates the structure of a portable peritoneal dialysis solution regeneration system.
  • the present invention relates to a filter for removing an element that is not removed from an activated carbon filter layer in a peritoneal dialysis solution of a patient, maintaining a proper pore and support structure, and effectively removing the element and a method of manufacturing the same.
  • the present invention relates to a filter for a regeneration system of a dialysate using silk fibroin, and a method for manufacturing the same, for example, urease, an urea removal enzyme for removing urea contained in the dialysate (urease) can be mixed to fix urease to the silk fibroin nanofibrous membrane.
  • Other enzymes can be immobilized on the filter to remove materials other than urea.
  • Silk fibroin filter according to the present invention can control the decomposition rate through the crystallization process, and can effectively fix enzymes such as urease during the crystallization process.
  • the silk fibroin aqueous solution is preferably in a concentration of 1 to 25 w / v%.
  • the present invention also provides a dialysis solution regeneration filter, characterized in that the urease, urease, which is directly mixed with an aqueous solution of silk fibroin or coated on an electrospun nanofiber membrane, for example, in order to promote urea decomposition. It relates to a manufacturing method.
  • the urea degrading enzyme may be immobilized in the process of producing nanofibers using silk fibroin, which is a natural polymer.
  • silk fibroin which is a natural polymer.
  • urease may be mixed together in a silk fibroin solution and then electrospun, so that the urease is evenly encapsulated in the silk fibroin nanofibers, and through crystallization, a membrane for urease-fixed filter may be manufactured.
  • the shape of the filter may be prepared in the form of nanofibers as well as nanofibers-beads, simple lyophilized sponges, size-controlled particles as well as nanofiber membranes.
  • the filter for the peritoneal dialysis solution regeneration system according to the present invention prepared as described above may be usefully used as a filter for effectively removing the elements in the dialysate.
  • the silk fibroin filter and the activated carbon filter layer may be used in combination to be used as a portable peritoneal dialysis solution regeneration filter.
  • the present invention also preferably further comprises insolubilizing the filter provided above.
  • the filter according to the present invention preferably has a structure in which a filter in which urease is immobilized and an activated carbon filter are separated (FIG. 6).
  • a filter in which urease is immobilized and an activated carbon filter are separated (FIG. 6).
  • FIG. 6 a filter in which urease is immobilized and an activated carbon filter are separated.
  • Silk fibroin protein is made by removing sericin from the cocoon.
  • the cocoon In order to remove sericin protein and impurities from the cocoon (Bombyx mori), the cocoon is heated in a basic aqueous solution such as sodium carbonate, heated and washed with distilled water.
  • Silk fibroin obtained through the above process is dissolved in a salt solution such as lithium bromide or calcium chloride to prepare a silk fibroin aqueous solution. It is then dialyzed with distilled water to remove ionic components from the solution.
  • Dialysis time is preferably 36 to 72 hours. If the dialysis time is less than 36 hours, the removal of ionic components may be insufficient, and exceeding 72 hours is an unnecessary process.
  • the silk fibroin aqueous solution is preferably in a concentration of 1 to 25 w / v%.
  • concentration of the aqueous solution of silk fibroin is less than 1 w / v%, the structure of the support is not firm, and when it exceeds 25 w / v%, the silk fibroin solution may become unstable and gel.
  • the silk fibroin aqueous solution is used to prepare a filter for a peritoneal dialysis solution regeneration system.
  • Polymer may be added to improve the properties of silk fibroin.
  • an aqueous solution of silk fibroin / polyethylene glycol is prepared by adding polyethylene glycol to increase the viscosity and radioactivity of the silk fibroin solution.
  • the volume ratio of the polymer and silk fibroin added at this time is preferably 1: 4 to 1: 5.
  • the silk fibroin is less than 4, it may be difficult to form a nanofiber structure because the viscosity is low, and when the silk fibroin is greater than 5, the viscosity may be too high to reduce radioactivity.
  • polyethylene glycol for changing physical properties
  • one or more selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like may be selected and added.
  • silk fibroin / polyethylene glycol / urease aqueous solution is prepared by mixing urease as urease.
  • activated carbon may be further mixed with the silk fibroin / polyethylene glycol / urease aqueous solution.
  • Peritoneal dialysis solution regeneration filter comprises a nanofiber type using an electrospinning method; A type in which nanofibers and beads are mixed using an electrospray method; Sponge type through lyophilization process; It can be produced in various forms, such as a particle type with adjustable size.
  • the aqueous solution is placed in a syringe and discharged using a delivery pump. At this time, connect the electrode to the syringe needle and apply a constant voltage to the DC power supply.
  • the formed silk nanofibers are collected on a rotating drum or stationary plate surface.
  • the aqueous solution is placed in an electric injector and discharged using a pressure. At this time, connect the electrode to the discharge port and apply a constant voltage to the DC power supply. The formed silk nanofibers and beads are collected on the stationary plate surface.
  • the aqueous solution is placed in a petri dish and frozen at an ultra low temperature, and then freeze-dried for 12 to 72 hours using a freeze dryer.
  • the particle type is prepared by slowly dropping the solution into droplet liquid nitrogen and quenching it, followed by a lyophilization process.
  • Silk fibroin filters have a low strength and are very susceptible to moisture and are preferably subjected to insolubilization.
  • the silk fibroin filter produced for this purpose is recrystallized.
  • the degree of degradation of the silk fibroin filter can be controlled and the enzyme can be immobilized on the silk fibroin. It can also control the dissolution rate of enzymes.
  • the resolution and elution rate can be controlled according to the silk fibroin crystallization time and method.
  • the crystallization time is preferably 3 to 24 hours. If it is less than 3 hours, crystallization may not occur, and if it exceeds 24 hours, maximum crystallinity is reached and unnecessary time is required. If the crystallization time of the silk fibroin is shortened, the release rate and degradation rate of the enzyme are increased. If the crystallization time is extended, the release rate and resolution of the silk fibroin are decreased.
  • the crystallization process for insolubilization of the manufactured silk fibroin filter may be crystallized by immersing in alcohol or treating with alcohol vapor.
  • the alcohol is preferably selected from one or more of the group consisting of methanol, ethanol, propanol and the like.
  • the crystallization for insolubilization may be carried out by treatment with water vapor.
  • the crystallinity is the lowest since the crystallization degree is the lowest compared to the crystallization with ethanol, methanol, propanol, etc., so that the release rate and degradation rate of the enzyme proceed rapidly.
  • crystallization is the highest when immersed in ethanol, methanol, propanol and the like crystallization.
  • Silk fibroin protein was prepared by removing sericin from the cocoon. To remove sericin protein and impurities from the cocoon (Bombyx mori), the cocoon was added to a basic aqueous solution such as sodium carbonate, heated, and washed with distilled water. Silk fibroin obtained through the above process was dissolved in CaCl 2 solution to prepare a silk fibroin aqueous solution of 10 w / v%. It was then dialyzed for 40 hours with distilled water to remove ionic components from the solution.
  • a basic aqueous solution such as sodium carbonate
  • the aqueous solution of silk fibroin / polyethylene glycol / urease was prepared by mixing urease which is a urease enzyme with the aqueous solution.
  • the aqueous solution was placed in a syringe and discharged using a delivery pump. At this time, the electrode was connected to the syringe needle and a constant voltage was applied to the DC power supply. The formed silk nanofibers were collected in a rotating drum.
  • Crystallization for insolubilization of the silk fibroin filter prepared above was crystallized by steam treatment of ethanol.
  • Activated carbon was added to 200 mL of the peritoneal dialysis solution, and the stirring time was adjusted to 0, 5, 10, 15, 20, 30, 50, 70, 100 and 120 minutes to observe the change of the peritoneal dialysis solution. Over time, the removal rate of uric acid, calcium and creatinine increased. Among them, creatinine, which is used as an indicator for renal dysfunction, showed the highest elimination rate of about 67%. Uric acid also showed an excellent removal rate of about 64% (FIG. 1).
  • Activated charcoal in 200mL peritoneal dialysis solution was adjusted to 0.1, 0.2, 0.5, 1.0, 2.0, 3.0g and stirred for 2 hours, and then the change of components of the peritoneal dialysis solution was observed.
  • the removal rate of each component increased.
  • creatinine and uric acid were confirmed to be removed more than 90% (Fig. 2).
  • FIG. 4 The structure of the membrane filter electrospun by mixing silk fibroin and urease was observed through FE-SEM.
  • FIG. 4 the upper photograph is a cross section of the membrane filter and the lower photograph is enlarged. It shows the shape.
  • the bottle top filter (Poyethersulfone) is in the form of microfibers with voids, and the silk fibroin filter (A), silk fibroin + activated carbon filter (B), silk fibroin + activated carbon + Urease filter (C) are all voids and nano A structure in which fibers and beads are mixed is formed. The pores allow the peritoneal dialysis solution to pass through, and the beads exhibit a structure containing urease or activated carbon.
  • the porosity was less than 20% for the filter that was electrospun on the roller, and the porosity was over 50% for the plate type.
  • the porosity represents the extent to which voids are formed per unit area. The higher the porosity, the better the permeability of the peritoneal dialysis solution.
  • the silk fibroin electrospun membrane was cut into a diameter of 25 mm and fixed to the filter holder, and then the peritoneal dialysis solution was removed by using a micro pump at a rate of 7 mL / min. Passed through and filtered. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemical measurements. Table 1 The concentrations of urea and creatinine were decreased and the removal rates were 3.0% and 1.83%, respectively.
  • the silk fibroin electrospun membrane was cut to a diameter of 25 mm and fixed to the filter holder, and then the peritoneal dialysis solution was 7 mL / min. Filtered by speed. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemical measurements (Table 1). The concentrations of urea and creatinine were decreased, and the removal rates were 3.46% and 3.47%, respectively.
  • Urease Is fixed silk Peritoneal Dialysis Solution Regeneration Effect of Fibroin and Activated Carbon Filter
  • the silk fibroin electrospun membrane was cut into 25mm diameter and fixed to the filter holder. After the peritoneal dialysis solution was filtered at a rate of 7 mL / min. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemistry measurement. (Table 1) The concentrations of urea and creatinine were decreased, and the removal rate was 5.46% and 3.62%, respectively.

Abstract

The present invention relates to a method for manufacturing a filter for a peritoneal dialysate regeneration system, using silk fibroin or silk protein and, more specifically, to a filter comprising silk fibroin or silk protein including an enzyme such as urease therein and to a method for manufacturing a filter for a portable peritoneal dialysate regeneration system. Silk fibroin, unlike the other polymers, does not induce an immune response in vivo, and was approved to be safe by FDA, and thus silk fibroin has been used for other medical materials including a suture thread. The filter according to the present invention can regenerate a peritoneal dialysate very effectively by effectively removing low-molecular materials. In addition, the filter of the present invention can be used simultaneously with an existing activated carbon filter, thereby allowing more effective regeneration of dialysate. The silk fibroin filter according to the present invention has advantages of mass productivity, regulatory degradability, and enzyme immobility, and thus has an excellent dialysate regeneration effect as a filter for a portable peritoneal dialysate regeneration system, in which an enzyme such as urease is immobilized.

Description

효소가 포접된 실크 피브로인을 이용한 휴대형 복막투석액 재생 시스템용 필터 및 그 제조 방법Filter for portable peritoneal dialysis solution regeneration system using silk fibroin entrapped with enzyme and method for producing same
본 발명은 휴대형 복막투석액 재생 시스템을 위한 필터 및 그 제조 방법에 관한 것으로서, 더욱 상세하게는 실크 피브로인 또는 실크 단백질에 효소가 포접된 휴대형 복막투석액 재생 시스템을 위한 필터 및 그 제조방법에 관한 것이다.The present invention relates to a filter for a portable peritoneal dialysis solution regeneration system, and more particularly, to a filter for a portable peritoneal dialysis solution regeneration system in which an enzyme is encapsulated in silk fibroin or silk protein.
서구화된 식습관과 생활방식의 확산으로 인해, 당뇨병 및 고혈압 등 생활습관형 대사성 질환이 꾸준히 증가되고 신장질환 환자의 수가 급속하게 증가되었다. 특히 국내 당뇨환자 400만명 중 30%는 말기신부전에 걸릴 가능성을 가지고 있을 만큼 신장질환에 대한 잠재수요가 급증하고 있다. Due to the spread of westernized eating habits and lifestyles, lifestyle-type metabolic diseases such as diabetes and hypertension have steadily increased and the number of patients with kidney disease has increased rapidly. In particular, 30% of the 4 million Korean diabetic patients have a potential increase in renal disease.
신장은 생물학적으로 생명 유지에 필요한 기능을 이행하는 장기로써 체내의 대사산물을 여과하여 소변으로 배설하는 기능 뿐만 아니라 산, 염기 평형을 조절하는 역할을 한다. 이러한 신장에 기능 장애가 생기면 혈액 내에 노폐물이 쌓여 요독증을 일으키며 생명을 위협하기도 한다. 말기신부전은 신장의 사구체 여과 기능이 영구적으로 감소되어 신장기능의 회복이 불가능한 상태로 신장 대체요법이 불가결하다. 따라서 말기신부전증 환자는 타인의 신장을 이식받거나, 인공신장기를 통해 혈액을 투석하거나, 복막 내에 체액과 비슷한 성분이 함유된 글루코스 용액을 넣고 일정 시간마다 교환해 주는 복막투석을 통해 요독증을 유발할 수 있는 노폐물 등을 제거한다.The kidney is a biological biological organ that performs the functions necessary to maintain life, and the function of filtering the metabolites in the body and excreted in the urine as well as regulating acid and base equilibrium. Dysfunction of these kidneys builds up waste products in the blood, causing uremia and life threatening. End stage renal failure is permanently reduced in the glomerular filtration function of the kidney is impossible to recover the kidney function is inevitable kidney replacement therapy. Therefore, patients with end-stage renal failure may receive urinary tract disease through transplantation of another person, dialysis of blood through artificial kidneys, or peritoneal dialysis with a glucose solution containing fluid-like components in the peritoneum and exchanged at regular intervals. Remove your back.
그러나 현재 혈액투석 치료로 인한 보험 재정부담은 매년 큰 폭으로 증가되고 있는 실정이고, 우리나라 심평원 자료에 의하면 말기 신부전 환자가 부담하는 총 의료비는 암 환자와 비슷하며, 환자 1인당 소요되는 의료비는 암 환자의 3배로 국내에서 가장 높다.However, the current financial burden of insurance due to hemodialysis treatment is increasing significantly, and according to the data of the Korean National Criminal Plain, the total medical expenses paid by patients with end-stage renal failure are similar to those of cancer patients. It is 3 times the highest in Korea.
신장 이식은 투석으로 제거되지 않는 중분자 물질도 제거할 수 있고, 조혈호르몬 등 호르몬 생성이 가능하며 정상적인 식사와 생활이 가능하다는 장점이 있지만, 장기 공여자 수가 장기이식을 기다리는 환자 수에 비해 현저히 부족한 실정이다. 또한 고령, 치료되지 않은 악성 종양, 조절되지 않는 감염 등이 동반된 경우 신장 이식을 고려하기 어렵다는 한계가 있고, 이식 후 거부반응이 올 수 있으며, 면역억제제를 평생 복용해야 하거나 암 발생을 포함한 약제 관련 부작용이 발생할 수 있다는 단점이 있다. 반면에 투석은 신부전으로 인한 체적 과부화, 고칼륨혈증, 질소노폐물에 의한 중독 등의 증상을 즉시 개선시키는 안전하고 효과적인 방법으로 알려져 있다.Kidney transplantation can remove the medium-molecular substances that cannot be removed by dialysis, and can produce hormones such as hematopoietic hormones and can eat and live normally, but the number of organ donors is significantly lower than the number of patients waiting for organ transplantation. to be. In addition, there is a limitation that it is difficult to consider renal transplantation in cases of old age, untreated malignant tumors, and uncontrolled infections, rejection after transplantation, and drug-related drugs, including the need for life-long immunosuppressants or cancer. The disadvantage is that side effects can occur. Dialysis, on the other hand, is known as a safe and effective way to immediately improve symptoms such as volume overload due to kidney failure, hyperkalemia and intoxication by nitrogen waste.
활성탄은 정수에 널리 사용되고 있으며, 야자각, 각종 목재류, 갈탄, 무연탄, 유연탄 등의 탄소질을 원료로 하여 활성화 과정을 통해 분자 크기 수준의 미세한 기공을 발달시킴으로써 물에 함유된 각종 이물질에 대한 흡착제 역할을 하는 것으로 1g 당 1000m2 이상의 내부 표면적을 갖는 특징이 있다. 이러한 활성탄은 저분자 물질과 고분자 물질을 흡착 할 수 있지만, 저분자 물질을 흡착했다가 더 큰 분자가 접촉할 경우 먼저 흡착했던 저분자를 탈착하고 더 큰 분자를 흡착하는 선택성을 가지고 있다. 이러한 선택성을 증가시키기 위해 활성탄은 산처리 등을 통하여 흡착에 대한 성질을 개선하기도 한다.Activated carbon is widely used for water purification, and it uses carbonaceous materials such as coconut shell, various woods, lignite, anthracite coal and bituminous coal as raw materials to develop fine pores of molecular size through the activation process. It is characterized by having an internal surface area of more than 1000m 2 per g. Such activated carbon can adsorb low molecular materials and high molecular materials, but it has the selectivity of adsorbing the low molecular materials and then desorbing the small molecules that are adsorbed first and adsorbing the larger molecules when larger molecules come into contact. In order to increase the selectivity, activated carbon may improve the properties for adsorption through acid treatment and the like.
환자의 복막투석액에는 요소(Urea), 칼슘(Calcium), 크레아티닌(Creatinine), 포도당(Glucose), 인(Phosphorus), 요산(Uric acid), 알부민(Albumin) 등이 투석되어 있다. 각 성분은 저분자, 중분자, 고분자 물질로 나뉘어 지는데, 요소(60 Dalton), 칼슘(40 Dalton), 인(30 Dalton)이 저분자 물질에 속하며, 크레아티닌(113 Dalton), 포도당(180 Dalton), 요산(168 Dalton)은 중분자 물질로 구분할 수 있고, 알부민은 65,000 Dalton으로 고분자 물질로 구분할 수 있다. 그러나 활성탄을 이용하여 환자의 복막투석액을 필터링 할 경우 중분자 물질인 크레아티닌과 요산은 활성탄에 흡착되어 제거 가능하지만, 저분자 물질인 요소의 경우 활성탄의 흡착선택성에 의해 초기에 흡착이 되더라도 중분자 물질에 의해 탈착되면서 제거 효과를 나타내지 못하는 단점이 있다.The peritoneal dialysis solution of the patient is urea (Calcium), creatinine (Creatinine), glucose (Glucose), phosphorus (Phosphorus), uric acid (Uric acid), albumin (Albumin) and the like. Each component is divided into small molecules, medium molecules, and high molecular materials. Urea (60 Dalton), calcium (40 Dalton), and phosphorus (30 Dalton) belong to low molecular materials, creatinine (113 Dalton), glucose (180 Dalton), and uric acid. (168 Dalton) can be classified as a medium molecule, and albumin can be classified as a polymer at 65,000 Dalton. However, in case of filtering peritoneal dialysis solution using activated carbon, creatinine and uric acid, which are medium molecules, can be adsorbed and removed by activated carbon.However, in the case of urea, which is a low molecular material, even if initially adsorbed due to adsorption selectivity of activated carbon, Desorption has a disadvantage that does not exhibit a removal effect.
실크는 누에로부터 얻을 수 있는 천연 고분자로 두 가닥의 피브로인 단백질을 세리신 단백질이 감싸고 있는 구조이며, 정련이라는 과정을 통해 세리신을 제거하여 피브로인 단백질을 얻을 수 있다. 실크 피브로인은 다른 고분자들과 달리 생체에서 면역반응을 유발하지 않고, FDA에서 안전성을 인정받아 봉합사 등 기타 의료용 소재로 사용되어지고 있다. 이러한 장점으로 실크 피브로인을 이용한 다양한 소재가 최근 속속 개발되고 있다.Silk is a natural polymer that can be obtained from silkworms. It is a structure in which two strands of fibroin protein are surrounded by sericin protein, and sericin is removed through a process called refining to obtain fibroin protein. Silk fibroin, unlike other polymers, does not induce an immune response in the living body and is used for other medical materials such as sutures because it is recognized for safety by the FDA. Due to these advantages, various materials using silk fibroin have been developed one after another.
실크 피브로인은 누에고치에서 추출한 단백질로 대량 생산이 가능하여 원가가 낮으며, 제조 형태 및 결정화 방법에 따라 분해도를 조절할 수 있는 고분자이다. 뿐만 아니라 결정화 과정 중 우레아제와 같은 효소 등을 효과적으로 고정할 수 있다는 장점이 있다. 이러한 실크 피브로인의 대량 생산성, 조절 가능한 분해성, 효소 고정성 등의 장점을 이용하여 본 발명자들은 우레아제와 같은 효소가 고정화된 휴대형 복막투석액 재생 시스템을 위한 필터를 제조하여 본 발명을 완성하였다.Silk fibroin is a protein extracted from silkworm cocoon, which can be mass-produced and low in cost, and is a polymer that can control the degree of decomposition depending on the production form and crystallization method. In addition, there is an advantage that can effectively fix enzymes such as urease during the crystallization process. Taking advantage of such mass productivity, controllable degradability, enzyme fixation, and the like of the silk fibroin, the present inventors have completed the present invention by preparing a filter for a portable peritoneal dialysis solution regeneration system to which an enzyme such as urease is immobilized.
본 발명은 말기 신부전 등의 환자가 가정에서 주기적으로 복막 투석을 할 경우, 효소가 고정화된 실크 피브로인 및 활성탄 필터를 이용하여 이미 사용된 투석액을 효과적으로 재생하므로써 환자의 삶의 질을 향상시키는데 그 목적이 있다.The present invention is to improve the quality of life of patients by effectively regenerating the dialysis solution already used by using the enzyme-immobilized silk fibroin and activated carbon filter when patients with end-stage renal failure periodically undergo peritoneal dialysis. have.
본 발명은 효소가 고정된 실크 피브로인 나노섬유를 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터를 제공한다. 상기 실크 피브로인 나노섬유에 폴리머가 첨가되는 것이 바람직하고, 상기 폴리머는 폴리에틸렌글리콜(polyethylene glycol), 폴리비닐알코올(polyvinyl alcohol), 폴리비닐리덴 플루오라이드(polyvinyliden fluoride) 등으로 이루어진 군 중에서 하나 이상을 선택하는 것이 더욱 바람직하다. 상기 효소는 우레아제일 수 있다. 상기 실크 피브로인 나노섬유에 활성탄을 더욱 포함할 수 있다.The present invention provides a filter for regenerating a peritoneal dialysis solution, wherein the enzyme comprises immobilized silk fibroin nanofibers. Preferably, a polymer is added to the silk fibroin nanofibers, and the polymer is selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like. More preferably. The enzyme may be urease. The silk fibroin nanofibers may further include activated carbon.
본 발명은 또한 효소가 고정된 실크 피브로인 나노섬유 필터층 및 활성탄 필터층을 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생 시스템을 제공한다. 상기 두 필터층들이 다층으로 포함되는 것이 바람직하다. The present invention also provides a portable peritoneal dialysis solution regeneration system comprising an enzyme-immobilized silk fibroin nanofiber filter layer and an activated carbon filter layer. Preferably, the two filter layers are included in multiple layers.
본 발명은 또한 실크 피브로인 수용액, 폴리머 및 효소를 혼합하여 실크 피브로인-폴리머-효소 혼합 수용액을 만드는 단계; 상기 혼합 수용액을 전기방사, 전기분사, 동결건조로 이루어진 군중에서 선택하여 필터를 제조하는 단계; 및 상기 제조된 필터를 불용화하는 단계를 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법을 제공한다. 상기 폴리머는 폴리에틸렌글리콜(polyethylene glycol), 폴리비닐알코올(polyvinyl alcohol), 폴리비닐리덴 플루오라이드(polyvinyliden fluoride) 등으로 이루어진 군 중에서 하나 이상을 선택하는 것이 바람직하다. 상기 불용화 단계는 에탄올, 메탄올, 프로판올으로 이루어진 군 중에서 하나 이상을 선택하여 상기 필터를 재결정화할 수 있다. 또한 상기 불용화 단계는 수증기로 처리하여 상기 필터를 재결정화할 수 있다. 상기 불용화 단계에서, 상기 효소를 상기 필터에 고정화 하는 단계를 동시에 수행할 수 있다. 상기 실크 피브로인-폴리머-효소 혼합 수용액을 만드는 단계에서 활성탄을 더욱 첨가하여 혼합 수용액을 만들 수 있다.The present invention also provides a method for preparing silk fibroin-polymer-enzyme mixed solution by mixing silk fibroin aqueous solution, polymer and enzyme; Preparing a filter by selecting the mixed aqueous solution from a crowd consisting of electrospinning, electrospraying, and lyophilization; And it provides a method for producing a portable peritoneal dialysis solution regeneration filter comprising the step of insolubilizing the prepared filter. The polymer is preferably at least one selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like. The insolubilization step may recrystallize the filter by selecting one or more of the group consisting of ethanol, methanol, propanol. The insolubilization step may also be treated with water vapor to recrystallize the filter. In the insolubilization step, the step of immobilizing the enzyme to the filter can be performed simultaneously. In the step of making the silk fibroin-polymer-enzyme mixed aqueous solution, activated carbon may be further added to form a mixed aqueous solution.
본 발명에 따른 필터는 저분자 물질을 효과적으로 제거하여 복막투석액을 매우 효과적으로 재생할 수 있다. 또한, 기존의 활성탄 필터와 동시에 사용 가능하므로 더욱 효과적인 투석액 재생이 가능하다.The filter according to the present invention can effectively remove the low molecular weight material and very effectively regenerate the peritoneal dialysis solution. In addition, since it can be used simultaneously with the existing activated carbon filter, more effective dialysis fluid regeneration is possible.
본 발명에 따른 실크 피브로인 필터는 대량 생산성, 조절가능한 분해성, 효소 고정성 등의 장점을 가지고 있어, 우레아제와 같은 효소가 고정화된 휴대형 복막투석액 재생 시스템을 위한 필터로 우수한 투석액 재생 효과를 가진다.The silk fibroin filter according to the present invention has advantages such as mass productivity, controllable degradability, enzyme fixation, and the like, and has an excellent dialysis solution regeneration effect as a filter for a portable peritoneal dialysis solution regeneration system to which an enzyme such as urease is immobilized.
도1은 복막투석액과 활성탄 교반시간 변화에 따른 복막투석액 성분들의 제거율에 대한 그래프이다.1 is a graph showing the removal rate of the peritoneal dialysis solution according to the change in the stirring time of the peritoneal dialysis solution and activated carbon.
도2는 복막투석액과 활성탄을 교반시 활성탄 투입량 변화에 따른 복막투석액 성분들의 제거율에 대한 그래프이다.Figure 2 is a graph of the removal rate of the peritoneal dialysis solution according to the change in the amount of activated carbon when stirring the peritoneal dialysis solution and activated carbon.
도3은 활성탄 필터를 컬럼에 채우고 복막투석액을 연속적으로 흘려주어 복막투석액의 성분 변화를 관찰한 결과이다.3 is a result of observing the change of the peritoneal dialysis solution by filling the activated carbon filter in the column and continuously flowing the peritoneal dialysis solution.
도4는 전기방사를 통해 제조된 실크 피브로인 필터의 구조를 SEM을 통해 관찰한 사진이다.Figure 4 is a photograph observing the structure of the silk fibroin filter produced by electrospinning through SEM.
도5는 전기방사를 통해 제조된 실크 피브로인 필터의 공극률을 나타낸 그래프이다. 5 is a graph showing the porosity of the silk fibroin filter produced by the electrospinning.
도6은 휴대형 복막투석액 재생 시스템 구조를 도식화하였다.Figure 6 illustrates the structure of a portable peritoneal dialysis solution regeneration system.
본 발명은 환자의 복막투석액 중 활성탄 필터 층에서 제거 되지 않는 요소를 제거하기 위한 필터로서, 적절한 공극과 지지구조를 유지하고, 요소를 효과적으로 제거하는 필터 및 그 제조 방법에 관한 것이다. 상기 목적을 달성하기 위해, 본 발명은 실크 피브로인을 이용한 투석액의 재생 시스템을 위한 필터 및 그 제조 방법에 관한 것으로서, 예를 들어 투석액에 함유되어 있는 요소(urea)를 제거하기 위한 요소 제거 효소인 우레아제(urease)를 혼합하여 실크 피브로인 나노 섬유막에 우레아제를 고정할 수 있다. 요소 이외의 다른 물질을 제거하기 위해 다른 효소를 필터에 고정할 수 있다. 본 발명에 따른 실크 피브로인 필터는 결정화 과정을 통해 분해 속도를 조절 할 수 있으며, 결정화 과정 중 우레아제와 같은 효소 등을 효과적으로 고정할 수 있다. 상기 실크 피브로인 수용액은 1 내지 25 w/v %의 농도가 바람직하다.The present invention relates to a filter for removing an element that is not removed from an activated carbon filter layer in a peritoneal dialysis solution of a patient, maintaining a proper pore and support structure, and effectively removing the element and a method of manufacturing the same. In order to achieve the above object, the present invention relates to a filter for a regeneration system of a dialysate using silk fibroin, and a method for manufacturing the same, for example, urease, an urea removal enzyme for removing urea contained in the dialysate (urease) can be mixed to fix urease to the silk fibroin nanofibrous membrane. Other enzymes can be immobilized on the filter to remove materials other than urea. Silk fibroin filter according to the present invention can control the decomposition rate through the crystallization process, and can effectively fix enzymes such as urease during the crystallization process. The silk fibroin aqueous solution is preferably in a concentration of 1 to 25 w / v%.
본 발명은 또한 상기 용액에 예를 들어, 요소 분해를 촉진하기 위해 요소 분해 효소인 우레아제 (urease)를 실크 피브로인 수용액에 직접 혼합하거나 전기방사 나노 섬유막에 코팅하는 것을 특징으로 하는 투석액 재생용 필터 및 그의 제조방법에 관한 것이다.The present invention also provides a dialysis solution regeneration filter, characterized in that the urease, urease, which is directly mixed with an aqueous solution of silk fibroin or coated on an electrospun nanofiber membrane, for example, in order to promote urea decomposition. It relates to a manufacturing method.
본 발명은 복막투석액 재생 시스템을 위한 필터의 효과를 극대화 시키기 위해, 천연 고분자인 실크 피브로인을 이용하여 나노 섬유를 제작하는 과정에 우레아 분해 효소를 고정화 할 수 있다. 예를 들어, 실크 피브로인 용액에 우레아제를 함께 혼합한 후 전기방사하여, 우레아제를 실크 피브로인 나노 섬유에 고르게 포접시키고, 결정화 과정을 통해, 우레아제를 고정한 필터용 멤브레인을 제작할 수 있다. 또한 필터의 형태는 나노 섬유막 뿐만 아니라 전기 분사(electrospray)를 이용한 나노섬유-비드 형태, 단순 동결건조 스펀지, 크기 조절이 가능한 입자형태 등으로 제조 될 수 있다. 이렇게 제조된 본 발명에 따른 상기 복막투석액 재생 시스템을 위한 필터는 투석액 내 요소를 효과적으로 제거하는 필터로 유용하게 사용될 수 있다. 또한 상기 실크 피브로인 필터와 활성탄 필터층을 복합적으로 사용하여 휴대형 복막투석액 재생용 필터로 사용할 수 있다.In order to maximize the effect of the filter for the peritoneal dialysis solution regeneration system, the urea degrading enzyme may be immobilized in the process of producing nanofibers using silk fibroin, which is a natural polymer. For example, urease may be mixed together in a silk fibroin solution and then electrospun, so that the urease is evenly encapsulated in the silk fibroin nanofibers, and through crystallization, a membrane for urease-fixed filter may be manufactured. In addition, the shape of the filter may be prepared in the form of nanofibers as well as nanofibers-beads, simple lyophilized sponges, size-controlled particles as well as nanofiber membranes. The filter for the peritoneal dialysis solution regeneration system according to the present invention prepared as described above may be usefully used as a filter for effectively removing the elements in the dialysate. In addition, the silk fibroin filter and the activated carbon filter layer may be used in combination to be used as a portable peritoneal dialysis solution regeneration filter.
본 발명은 또한 상기 제공된 필터를 불용화 하는 단계를 더욱 포함하는 것이 바람직하다.The present invention also preferably further comprises insolubilizing the filter provided above.
본 발명에 따른 필터는 예를 들어, 우레아제가 고정화된 필터와 활성탄 필터가 구분된 구조(도 6)가 바람직하다. 환자의 복막투석액을 효과적으로 재생하기 위하여, 예를 들어 도 9에 도시된 바와 같이 우레아제가 고정화된 필터층과 활성탄 필터층으로 구분하여, 복막투석액이 각 단계를 거치도록 하므로써 요소, 크레아티닌, 요산 등을 효과적으로 제거 할 수 있다. For example, the filter according to the present invention preferably has a structure in which a filter in which urease is immobilized and an activated carbon filter are separated (FIG. 6). In order to effectively regenerate the peritoneal dialysis solution of the patient, for example, as shown in Figure 9 divided into urease-immobilized filter layer and activated charcoal filter layer, by removing the urea, creatinine, uric acid, etc. by allowing the peritoneal dialysis solution to go through each step can do.
본 발명을 일실시예를 예로 하여 설명한다.The present invention will be described by taking an embodiment as an example.
나노 섬유 원액의 준비Preparation of Nanofiber Stock
실크 피브로인 단백질은 누에고치로부터 세리신을 제거하여 제조된다. 누에고치(Bombyx mori)로부터 세리신 단백질 및 불순물 등을 제거하기 위해, 누에고치를 탄산나트륨 등의 염기성 수용액에 넣고 가열한 후 증류수로 세척한다. 상기 과정을 거쳐 얻은 실크 피브로인을 브롬화리튬 또는 염화칼슘 등의 염 용액에 넣고 용해시켜 실크 피브로인 수용액을 제조한다. 그런 다음, 상기 용액으로부터 이온 성분을 제거하기 위해 증류수로 투석한다. 투석 시간은 36 내지 72시간이 바람직하다. 상기 투석시간이 36시간 미만이면 이온 성분의 제거가 불충분할 수 있고, 72시간 초과하는 것은 불필요한 과정이다. 상기 실크피브로인 수용액은 1 내지 25 w/v %의 농도가 바람직하다. 상기 실크 피브로인 수용액의 농도가 1 w/v% 미만이면 지지체의 구조가 단단하지 못하고, 25 w/v% 초과일 경우 실크 피브로인 용액이 불안정한 상태가 되어 겔화될 우려가 있다.Silk fibroin protein is made by removing sericin from the cocoon. In order to remove sericin protein and impurities from the cocoon (Bombyx mori), the cocoon is heated in a basic aqueous solution such as sodium carbonate, heated and washed with distilled water. Silk fibroin obtained through the above process is dissolved in a salt solution such as lithium bromide or calcium chloride to prepare a silk fibroin aqueous solution. It is then dialyzed with distilled water to remove ionic components from the solution. Dialysis time is preferably 36 to 72 hours. If the dialysis time is less than 36 hours, the removal of ionic components may be insufficient, and exceeding 72 hours is an unnecessary process. The silk fibroin aqueous solution is preferably in a concentration of 1 to 25 w / v%. When the concentration of the aqueous solution of silk fibroin is less than 1 w / v%, the structure of the support is not firm, and when it exceeds 25 w / v%, the silk fibroin solution may become unstable and gel.
상기 실크 피브로인 수용액을 이용하여 복막투석액 재생 시스템을 위한 필터를 제조한다. 실크 피브로인의 물성 개선을 위해 폴리머를 첨가할 수 있다. 예를 들면, 실크 피브로인 용액의 점도 및 방사성을 증가시키기 위해 폴리에틸렌글리콜(polyethylene glycol)을 첨가하여 실크 피브로인/폴리에틸렌글리콜 수용액을 제조한다. 이때 첨가되는 폴리머와 실크 피브로인의 부피비는 1:4 내지 1:5인 것이 바람직하다. 상기 실크 피브로인이 4 미만이면 점도가 낮아 나노섬유 구조를 형성하기 어려울 수 있고, 5를 초과하면 점도가 너무 높아 방사성이 감소할 수 있다. 상기 폴리머로서, 물성 변화를 위해, 폴리에틸렌글리콜(polyethylene glycol), 폴리비닐알코올(polyvinyl alcohol), 폴리비닐리덴 플루오라이드(polyvinyliden fluoride) 등으로 이루어진 군 중에서 하나 이상을 선택하여 첨가할 수 있다. 상기 수용액에 요소 분해 효소인 우레아제를 혼합하여 예를 들어, 실크 피브로인/폴리에틸렌글리콜/우레아제 수용액을 준비한다. 또한, 활성탄을 더욱 포함하는 필터를 제조하는 경우, 상기 실크 피브로인/폴리에틸렌글리콜/우레아제 수용액에 활성탄을 더욱 혼합할 수 있다.The silk fibroin aqueous solution is used to prepare a filter for a peritoneal dialysis solution regeneration system. Polymer may be added to improve the properties of silk fibroin. For example, an aqueous solution of silk fibroin / polyethylene glycol is prepared by adding polyethylene glycol to increase the viscosity and radioactivity of the silk fibroin solution. The volume ratio of the polymer and silk fibroin added at this time is preferably 1: 4 to 1: 5. When the silk fibroin is less than 4, it may be difficult to form a nanofiber structure because the viscosity is low, and when the silk fibroin is greater than 5, the viscosity may be too high to reduce radioactivity. As the polymer, for changing physical properties, one or more selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like may be selected and added. For example, silk fibroin / polyethylene glycol / urease aqueous solution is prepared by mixing urease as urease. In addition, when preparing a filter further comprising activated carbon, activated carbon may be further mixed with the silk fibroin / polyethylene glycol / urease aqueous solution.
복막투석액 재생용 필터를 제조하는 공정Process for producing peritoneal dialysis fluid regeneration filter
복막투석액 재생용 필터는 전기 방사(electrospinning)법을 이용한 나노 섬유 타입; 전기 분사(electrospray)법을 이용한 나노섬유와 비드(bead)가 혼합된 타입; 동결건조 과정을 통한 스펀지 타입; 크기 조절이 가능한 입자 타입 등 여러 가지 형태로 제작할 수 있다.Peritoneal dialysis solution regeneration filter comprises a nanofiber type using an electrospinning method; A type in which nanofibers and beads are mixed using an electrospray method; Sponge type through lyophilization process; It can be produced in various forms, such as a particle type with adjustable size.
예를 들어, 전기 방사법를 이용한 필터의 제조 방법으로는 상기 수용액을 주사기에 담고 송출펌프를 이용하여 토출한다. 이때 주사기 바늘에 전극을 연결하여 직류전원장치로 정전압을 가한다. 형성된 실크 나노 섬유를 회전형 드럼 또는 고정형 판 표면에 수집한다.For example, in the manufacturing method of the filter using the electrospinning method, the aqueous solution is placed in a syringe and discharged using a delivery pump. At this time, connect the electrode to the syringe needle and apply a constant voltage to the DC power supply. The formed silk nanofibers are collected on a rotating drum or stationary plate surface.
예를 들어, 전기 분사법을 이용한 필터 제조 방법으로는 상기 수용액을 전기 분사기에 담고 프레셔를 이용하여 토출한다. 이때 토출구에 전극을 연결하여 직류전원장치로 정전압을 가한다. 형성된 실크 나노섬유와 비드는 고정형 판 표면에 수집한다.For example, in the filter manufacturing method using the electric injection method, the aqueous solution is placed in an electric injector and discharged using a pressure. At this time, connect the electrode to the discharge port and apply a constant voltage to the DC power supply. The formed silk nanofibers and beads are collected on the stationary plate surface.
예를 들어, 동결건조법을 이용한 필터 제조 방법으로는 상기 수용액을 페트리디쉬에 담고 초저온에서 냉동시킨 후 동결건조기를 이용해 12시간 내지 72시간 동안 동결 건조하여 제조한다.For example, in the filter manufacturing method using the freeze-drying method, the aqueous solution is placed in a petri dish and frozen at an ultra low temperature, and then freeze-dried for 12 to 72 hours using a freeze dryer.
예를 들어, 입자타입은 상기 용액을 방울방울 액체 질소에 천천히 떨어뜨려 급랭시킨 다음 동결건조 과정을 거쳐 제조한다.For example, the particle type is prepared by slowly dropping the solution into droplet liquid nitrogen and quenching it, followed by a lyophilization process.
실크 피브로인 불용화 및 효소 고정하는 공정Silk fibroin insolubilization and enzyme immobilization process
실크 피브로인 필터는 강도가 약하고 습기에 매우 취약하므로 불용화 처리 공정을 거치는 것이 바람직하다. 이를 위해 제조된 실크 피브로인 필터를 재결정화한다. 이러한 불용화 처리 과정에서 실크 피브로인 필터의 분해도를 조절할 수 있으며, 효소를 실크 피브로인에 고정화 할 수 있다. 또한 효소의 용출 속도를 조절 할 수 있다. 분해도 및 용출 속도는 실크 피브로인 결정화 시간 및 방법에 따라 조절할 수 있다. 상기 결정화 시간은 3 내지 24 시간이 바람직하다. 3시간 미만이면 결정화가 일어나지 않을 수 있고, 24시간을 초과하면 최대 결정화도에 도달하여 불필요한 시간이 소요 된다. 상기 실크 피브로인 결정화 시간을 짧게 하면 효소가 방출되는 속도와 분해도가 빠르게 되며, 결정화 시간을 길게 하면 방출 속도와 분해도는 느려지게 된다. Silk fibroin filters have a low strength and are very susceptible to moisture and are preferably subjected to insolubilization. The silk fibroin filter produced for this purpose is recrystallized. In this insolubilization process, the degree of degradation of the silk fibroin filter can be controlled and the enzyme can be immobilized on the silk fibroin. It can also control the dissolution rate of enzymes. The resolution and elution rate can be controlled according to the silk fibroin crystallization time and method. The crystallization time is preferably 3 to 24 hours. If it is less than 3 hours, crystallization may not occur, and if it exceeds 24 hours, maximum crystallinity is reached and unnecessary time is required. If the crystallization time of the silk fibroin is shortened, the release rate and degradation rate of the enzyme are increased. If the crystallization time is extended, the release rate and resolution of the silk fibroin are decreased.
본 발명에서는 제작된 실크 피브로인 필터의 불용화를 위한 결정화 과정은 알코올에 침지하거나 알코올 증기로 처리하여 결정화할 수 있다. 상기 알코올은 메탄올, 에탄올, 프로판올 등으로 이루어진 군 중에서 하나 이상을 선택하는 것이 바람직하다. 또한, 상기 불용화를 위한 결정화는 수증기로 처리하여 수행할 수도 있다. 수증기에 노출시켜 결정화 할 경우 에탄올이나 메탄올, 프로판올 등으로 결정화 할 때와 비교하여 볼 때, 결정화도가 가장 낮아서 전체적인 결정화도는 감소함으로, 효소의 방출속도와 분해도가 빠르게 진행된다. 그리고 에탄올, 메탄올, 프로판올 등에 침지하여 결정화 할 경우 가장 결정화도가 높게 나타난다.In the present invention, the crystallization process for insolubilization of the manufactured silk fibroin filter may be crystallized by immersing in alcohol or treating with alcohol vapor. The alcohol is preferably selected from one or more of the group consisting of methanol, ethanol, propanol and the like. In addition, the crystallization for insolubilization may be carried out by treatment with water vapor. When crystallized by exposure to water vapor, the crystallinity is the lowest since the crystallization degree is the lowest compared to the crystallization with ethanol, methanol, propanol, etc., so that the release rate and degradation rate of the enzyme proceed rapidly. And crystallization is the highest when immersed in ethanol, methanol, propanol and the like crystallization.
[실시예 1]Example 1
1) 나노 섬유 원액의 준비1) Preparation of Nanofiber Stock Solution
실크 피브로인 단백질은 누에고치로부터 세리신을 제거하여 제조되었다. 누에고치(Bombyx mori)로부터 세리신 단백질 및 불순물 등을 제거하기 위해, 누에고치를 탄산나트륨 등의 염기성 수용액에 넣고 가열한 후 증류수로 세척했다. 상기 과정을 거쳐 얻은 실크 피브로인을 CaCl2 용액에 넣고 용해시켜 10 w/v%의 실크 피브로인 수용액을 제조했다. 그런 다음, 상기 용액으로부터 이온 성분을 제거하기 위해 증류수로 40시간 동안 투석했다. Silk fibroin protein was prepared by removing sericin from the cocoon. To remove sericin protein and impurities from the cocoon (Bombyx mori), the cocoon was added to a basic aqueous solution such as sodium carbonate, heated, and washed with distilled water. Silk fibroin obtained through the above process was dissolved in CaCl 2 solution to prepare a silk fibroin aqueous solution of 10 w / v%. It was then dialyzed for 40 hours with distilled water to remove ionic components from the solution.
상기 실크 피브로인 수용액 20 mL에 분자량이 200,000인 30% 폴리에틸렌글리콜(polyethylene glycol) 수용액 4 mL 을 첨가하여 실크 피브로인/폴리에틸렌글리콜 수용액을 제조했다. To 20 mL of the silk fibroin aqueous solution, 4 mL of a 30% polyethylene glycol aqueous solution having a molecular weight of 200,000 was added to prepare a silk fibroin / polyethylene glycol aqueous solution.
상기 수용액에 요소 분해 효소인 우레아제를 혼합하여 실크 피브로인/폴리에틸렌글리콜/우레아제 수용액을 준비했다.The aqueous solution of silk fibroin / polyethylene glycol / urease was prepared by mixing urease which is a urease enzyme with the aqueous solution.
2) 복막투석액 재생용 필터 제조하는 공정2) Process for manufacturing peritoneal dialysis solution regeneration filter
전기 방사법를 이용한 필터의 제조 방법으로서, 상기 수용액을 주사기에 담고 송출펌프를 이용하여 토출했다. 이때 주사기 바늘에 전극을 연결하여 직류전원장치로 정전압을 가했다. 형성된 실크 나노 섬유를 회전형 드럼에 수집했다.As a method for producing a filter using an electrospinning method, the aqueous solution was placed in a syringe and discharged using a delivery pump. At this time, the electrode was connected to the syringe needle and a constant voltage was applied to the DC power supply. The formed silk nanofibers were collected in a rotating drum.
3) 실크 피브로인 불용화 및 효소 고정하는 공정3) Silk fibroin insolubilization and enzyme immobilization process
상기 제조된 실크 피브로인 필터의 불용화를 위한 결정화는, 에탄올을 증기 처리하여 결정화 하였다.Crystallization for insolubilization of the silk fibroin filter prepared above was crystallized by steam treatment of ethanol.
4) 환자의 복막투석액을 이용한 활성탄의 흡착 실험4) Adsorption experiment of activated carbon using peritoneal dialysis solution
활성탄을 이용한 필터의 복막투석액 재생 효과를 관찰하기 위하여 회분식과 연속식 실험을 시행하였다. 각 실험은 다음과 같이 진행하였다.Batch and continuous experiments were performed to observe the peritoneal dialysis solution regeneration effect of activated carbon filters. Each experiment was carried out as follows.
① 교반시간 변화에 따른 복막투석액 성분 제거 특성 (회분식실험I)① Removal Characteristics of Peritoneal Dialysis Solution According to the Change of Stirring Time (Batch Test I)
복막투석액 200mL에 활성탄을 넣고, 교반 시간을 0, 5, 10, 15, 20, 30, 50, 70, 100, 120분으로 조절하여 복막투석액 성분 변화를 관찰하였다. 시간이 경과함에 따라 요산과 칼슘, 크레아티닌의 제거율이 증가하였다. 그 중 신장기능 이상을 확인하는 지표로 사용되는 크레아티닌이 약 67%로 가장 높은 제거율을 보여주었다. 요산 역시 약 64%로 우수한 제거율을 나타내었다.(도 1)Activated carbon was added to 200 mL of the peritoneal dialysis solution, and the stirring time was adjusted to 0, 5, 10, 15, 20, 30, 50, 70, 100 and 120 minutes to observe the change of the peritoneal dialysis solution. Over time, the removal rate of uric acid, calcium and creatinine increased. Among them, creatinine, which is used as an indicator for renal dysfunction, showed the highest elimination rate of about 67%. Uric acid also showed an excellent removal rate of about 64% (FIG. 1).
② 활성탄 투입량 변화에 따른 복막투석액 성분 제거 특성 (회분식실험II)② Removal Characteristics of Peritoneal Dialysis Solution According to the Change of Activated Carbon Intake (Batch Experiment II)
복막투석액 200mL에 활성탄 투입량을 0.1, 0.2, 0.5, 1.0, 2.0, 3.0g으로 조절하여 2시간동안 교반시킨 후 복막투석액의 성분 변화를 관찰하였다. 활성탄 투입량이 증가할수록 각 성분의 제거율은 증가하였다. 그 중 크레아티닌과 요산은 90% 이상 제거되는 것을 확인하였다.(도 2)Activated charcoal in 200mL peritoneal dialysis solution was adjusted to 0.1, 0.2, 0.5, 1.0, 2.0, 3.0g and stirred for 2 hours, and then the change of components of the peritoneal dialysis solution was observed. As activated charcoal input increased, the removal rate of each component increased. Among them, creatinine and uric acid were confirmed to be removed more than 90% (Fig. 2).
③ 연속식 실험③ continuous experiment
연속식 실험은 활성탄 1g을 컬럼에 채운 뒤 펌프로 2mL/min 속도로 복막투석액을 흘려주었다. 0, 10, 20, 30, 60, 90, 120, 150, 180, 210, 240분에 시료를 채취하여 복막투석액의 성분 변화를 관찰하였다. 활성탄 필터에 환자의 복막투석액을 연속적으로 통과시켰을 때, 10분에서 크레아티닌과 요산의 제거율이 가장 높았으며, 시간이 흐름에 따라 제거율은 점점 감소하는 것으로 보아 활성탄의 흡착능 감소하는 것을 알수 있었다. 인의 경우 60분에서 흡착제거율이 가장 높았으며, 시간이 지날수록 제거율이 유지되었다.(도 3)In the continuous experiment, 1 g of activated carbon was charged to the column, and the peritoneal dialysis solution was flowed at a rate of 2 mL / min by a pump. Samples were taken at 0, 10, 20, 30, 60, 90, 120, 150, 180, 210, and 240 minutes to observe changes in the components of the peritoneal dialysis solution. When peritoneal dialysis solution was passed through the activated carbon filter, the removal rate of creatinine and uric acid was the highest at 10 minutes, and the removal rate gradually decreased with time, indicating that the adsorption capacity of activated carbon decreased. In the case of phosphorus, the adsorption removal rate was the highest at 60 minutes, and the removal rate was maintained over time (FIG. 3).
5) 실크 피브로인/우레아제 필터의 구조5) Structure of silk fibroin / urease filter
실크 피브로인과 우레아제를 혼합하여 전기방사 한 멤브레인 필터의 구조를 FE-SEM을 통해 관찰하였다.(도 4) 도 4에서, 상부의 사진은 멤브레인 필터의 단면이고, 하부의 사진은 확대된 것으로서 입자들의 형상을 보여주는 것이다. 대조군인 바틀탑 필터(Poyethersulfone)에서는 공극이 있는 마이크로 섬유의 형태이며, 실크 피브로인 필터(A), 실크 피브로인+활성탄 필터(B), 실크 피브로인+활성탄+Urease 필터(C)는 모두 공극이 있고 나노섬유와 비드가 혼재되어 있는 구조를 형성하고 있다. 공극은 복막투석액이 통과될 수 있도록 하며, 비드는 Urease나 활성탄이 포접되어 있는 구조를 나타낸다. The structure of the membrane filter electrospun by mixing silk fibroin and urease was observed through FE-SEM. (FIG. 4) In FIG. 4, the upper photograph is a cross section of the membrane filter and the lower photograph is enlarged. It shows the shape. In the control bottle, the bottle top filter (Poyethersulfone) is in the form of microfibers with voids, and the silk fibroin filter (A), silk fibroin + activated carbon filter (B), silk fibroin + activated carbon + Urease filter (C) are all voids and nano A structure in which fibers and beads are mixed is formed. The pores allow the peritoneal dialysis solution to pass through, and the beads exhibit a structure containing urease or activated carbon.
6) 실크 피브로인 필터의 공극률6) Porosity of Silk Fibroin Filter
실크 피브로인 필터의 공극을 조절하기 위해 전기방사 콜렉터를 롤러 타입과 플레이트 타입으로 구분하여 전기방사를 시행하였고, 각 전기방사 필터의 공극률을 확인하였다. 공극률은 다음과 같은 식으로 측정하였다. (n=3)In order to control the voids of the silk fibroin filter, electrospinning was performed by dividing the electrospinning collector into a roller type and a plate type, and the porosity of each electrospinning filter was confirmed. Porosity was measured by the following equation. (n = 3)
Figure PCTKR2016000531-appb-I000001
Figure PCTKR2016000531-appb-I000001
롤러에 전기방사를 받은 필터의 경우 공극률이 20% 미만으로 나타났으며, 플레이트 타입으로 받은 경우 모두 50% 이상의 공극률을 보여주었다. 공극률은 단위면적당 공극이 형성되어있는 정도를 나타내는 것으로, 공극률이 높을수록 복막투석액의 투과율이 좋게 된다. The porosity was less than 20% for the filter that was electrospun on the roller, and the porosity was over 50% for the plate type. The porosity represents the extent to which voids are formed per unit area. The higher the porosity, the better the permeability of the peritoneal dialysis solution.
7) 실크 피브로인 필터의 복막투석액 재생 효과7) Peritoneal Dialysis Solution Regeneration Effect of Silk Fibroin Filter
실크 피브로인을 전기방사하여 제작한 필터의 복막투석액 재생 효과를 관찰하기 위하여, 실크 피브로인 전기방사 멤브레인을 직경 25mm 크기로 절단하여 필터홀더에 고정시킨 후, 마이크로 펌프를 이용해 복막투석액을 7 mL/min 속도로 통과시키고 필터링 하였다. 10분후 필터링된 복막투석액을 취하여 혈액생화학 측정을 하였다.(표1) 요소(Urea)와 크레아티닌(creatinine)의 농도가 감소하여 제거율이 각각 3.0%, 1.83% 였다.In order to observe the peritoneal dialysis solution regeneration effect of the filter produced by electrospinning the silk fibroin, the silk fibroin electrospun membrane was cut into a diameter of 25 mm and fixed to the filter holder, and then the peritoneal dialysis solution was removed by using a micro pump at a rate of 7 mL / min. Passed through and filtered. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemical measurements. Table 1 The concentrations of urea and creatinine were decreased and the removal rates were 3.0% and 1.83%, respectively.
8) 실크 피브로인과 활성탄이 혼합된 필터의 복막투석액 재생 효과8) Peritoneal Dialysis Solution Regeneration Effect of Filters Mixed with Silk Fibroin and Activated Carbon
실크 피브로인과 활성탄을 3way법으로 전기방사하여 제작한 필터의 복막투석액 재생 효과를 관찰하기 위하여, 실크 피브로인 전기방사 멤브레인을 직경 25mm 크기로 절단하여 필터홀더에 고정시킨 후, 복막투석액을 7 mL/min 속도로 필터링 하였다. 10분후 필터링 된 복막투석액을 취하여 혈액생화학 측정을 하였다.(표1) 요소(Urea)와 크레아티닌(creatinine)의 농도가 감소하여 제거율이 각각 3.46%, 3.47% 였다.In order to observe the peritoneal dialysis solution regeneration effect of the filter produced by electrospinning the silk fibroin and activated carbon by the 3-way method, the silk fibroin electrospun membrane was cut to a diameter of 25 mm and fixed to the filter holder, and then the peritoneal dialysis solution was 7 mL / min. Filtered by speed. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemical measurements (Table 1). The concentrations of urea and creatinine were decreased, and the removal rates were 3.46% and 3.47%, respectively.
9) 우레아제(9) urease ( UreaseUrease )가 고정화된 ) Is fixed 실크silk 피브로인과 활성탄 필터의 복막투석액 재생 효과 Peritoneal Dialysis Solution Regeneration Effect of Fibroin and Activated Carbon Filter
실크 피브로인과 우레아제(urease)를 혼합한 용액과 활성탄 용액을 3way법으로 전기방사하여 제작한 필터의 복막투석액 재생 효과를 관찰하기 위하여, 실크 피브로인 전기방사 멤브레인을 직경 25mm 크기로 절단하여 필터홀더에 고정시킨 후, 복막투석액을 7 mL/min 속도로 필터링하였다. 10분후 필터링 된 복막투석액을 취하여 혈액생화학 측정을 하였다.(표1) 요소(Urea)와 크레아티닌(creatinine)의 농도가 감소하여 제거율이 각각 5.46%, 3.62% 였다.In order to observe the peritoneal dialysis solution regeneration effect of the filter produced by electrospinning the solution of silk fibroin and urease and activated carbon by 3way method, the silk fibroin electrospun membrane was cut into 25mm diameter and fixed to the filter holder. After the peritoneal dialysis solution was filtered at a rate of 7 mL / min. After 10 minutes, the filtered peritoneal dialysis solution was taken for blood biochemistry measurement. (Table 1) The concentrations of urea and creatinine were decreased, and the removal rate was 5.46% and 3.62%, respectively.
요소 농도Urea concentration 크레아티닌 농도Creatinine Concentration
샘플Sample 10분필터후After 10 minutes filter 제거율Removal rate 샘플Sample 10분필터후After 10 minutes filter 제거율Removal rate
실크피브로인필터Silk Fibroin Filter 16.3116.31 15.8215.82 3.00%3.00% 2.792.79 2.742.74 1.83%1.83%
실크피브로인과 활성탄 혼합필터Silk Fibroin and Activated Carbon Blend Filter 17.9317.93 17.3117.31 3.46%3.46% 2.772.77 2.672.67 3.47%3.47%
우레아제 고정 실크 피브로인과 활성탄 필터Urease Fixed Silk Fibroin and Activated Carbon Filter 16.3116.31 15.4215.42 5.46%5.46% 2.792.79 2.692.69 3.62%3.62%
상기 실시예는 발명의 이해를 용이하게 하기 위한 것일 뿐, 본 발명이 이에 한정되는 것으로 여겨져서는 안된다. The above examples are only for facilitating the understanding of the present invention, and the present invention should not be considered as being limited thereto.

Claims (12)

  1. 효소가 고정된 실크 피브로인 나노섬유를 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터.Portable peritoneal dialysis fluid regeneration filter, characterized in that it comprises an enzyme-immobilized silk fibroin nanofibers.
  2. 제 1항에 있어서, 상기 실크 피브로인 나노섬유에 폴리머가 첨가된 것을 특징으로 하는 휴대형 복막투석액 재생용 필터.The filter of claim 1, wherein a polymer is added to the silk fibroin nanofibers.
  3. 제 2항에 있어서, 상기 폴리머는 폴리에틸렌글리콜(polyethylene glycol), 폴리비닐알코올(polyvinyl alcohol), 폴리비닐리덴 플루오라이드(polyvinyliden fluoride) 등으로 이루어진 군 중에서 하나 이상을 선택하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터.The portable peritoneal dialysis solution according to claim 2, wherein the polymer is selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like. Filter for playback.
  4. 제 1항에 있어서, 상기 효소는 우레아제인 것을 특징으로 하는 휴대형 복막투석액 재생용 필터.The portable peritoneal dialysis fluid regeneration filter according to claim 1, wherein the enzyme is urease.
  5. 제 1항에 있어서, 상기 실크 피브로인 나노섬유에 활성탄이 더욱 포함되어 있는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터.The portable peritoneal dialysis fluid regeneration filter according to claim 1, wherein the silk fibroin nanofiber further comprises activated carbon.
  6. 효소가 고정된 실크 피브로인 나노섬유 필터층 및 활성탄 필터층을 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생 시스템.A portable peritoneal dialysis fluid regeneration system, comprising an enzyme-immobilized silk fibroin nanofiber filter layer and an activated carbon filter layer.
  7. 제 6항에 있어서, 상기 실크 피브로인 나노섬유 필터층 및 활성탄 필터층들이 다층으로 포함되는 것을 특징으로 하는 휴대형 복막투석액 재생 시스템.The portable peritoneal dialysis solution regeneration system according to claim 6, wherein the silk fibroin nanofiber filter layer and the activated carbon filter layers are included in a multilayer.
  8. 실크 피브로인 수용액, 폴리머 및 효소를 혼합하여 실크 피브로인-폴리머-효소 혼합 수용액을 만드는 단계;Mixing a silk fibroin aqueous solution, a polymer, and an enzyme to form a silk fibroin-polymer-enzyme mixed aqueous solution;
    상기 혼합 수용액을 전기방사, 전기분사, 동결건조로 이루어진 군중에서 선택하여 필터를 제조하는 단계; 및Preparing a filter by selecting the mixed aqueous solution from a crowd consisting of electrospinning, electrospraying, and lyophilization; And
    상기 제조된 필터를 불용화하는 단계를 포함하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법.Method for producing a portable peritoneal dialysis solution regeneration filter comprising the step of insolubilizing the prepared filter.
  9. 제 8항에 있어서, 상기 폴리머는 폴리에틸렌글리콜(polyethylene glycol), 폴리비닐알코올(polyvinyl alcohol), 폴리비닐리덴 플루오라이드(polyvinyliden fluoride) 등으로 이루어진 군 중에서 하나 이상을 선택하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법.The portable peritoneal dialysis solution according to claim 8, wherein the polymer is selected from the group consisting of polyethylene glycol, polyvinyl alcohol, polyvinyliden fluoride, and the like. Method for producing filter for regeneration.
  10. 제 8항에 있어서, 상기 불용화 단계는 에탄올, 메탄올, 프로판올으로 이루어진 군 중에서 하나 이상을 선택하여 상기 필터를 재결정화하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법.The method of claim 8, wherein the insolubilization step comprises recrystallizing the filter by selecting one or more selected from the group consisting of ethanol, methanol, and propanol.
  11. 제 8항에 있어서, 상기 불용화 단계는 수증기로 처리하여 상기 필터를 재결정화하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법.9. The method according to claim 8, wherein the insolubilization step comprises recrystallizing the filter by treating with water vapor.
  12. 제 8항에 있어서, 상기 불용화 단계에서, 상기 효소를 상기 필터에 고정화 하는 단계를 동시에 수행하는 것을 특징으로 하는 휴대형 복막투석액 재생용 필터의 제조 방법.The method of claim 8, wherein in the insolubilization step, the step of immobilizing the enzyme to the filter is performed simultaneously.
PCT/KR2016/000531 2015-03-31 2016-01-19 Filter for portable peritoneal dialysate regeneration system using enzyme-included silk fibroin and method for manufacturing same WO2016159500A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0045643 2015-03-31
KR1020150045643A KR101634205B1 (en) 2015-03-31 2015-03-31 Filter for portable peritoneal dialysis system using silk fibroin including enzyme and method thereof

Publications (1)

Publication Number Publication Date
WO2016159500A1 true WO2016159500A1 (en) 2016-10-06

Family

ID=56366396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/000531 WO2016159500A1 (en) 2015-03-31 2016-01-19 Filter for portable peritoneal dialysate regeneration system using enzyme-included silk fibroin and method for manufacturing same

Country Status (2)

Country Link
KR (1) KR101634205B1 (en)
WO (1) WO2016159500A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109337892A (en) * 2018-11-27 2019-02-15 贺州学院 The method of the fixed taro polyphenol oxidase of fibroin
CN109385710A (en) * 2018-09-12 2019-02-26 浙江星月生物科技股份有限公司 A kind of absorbable suture and preparation method thereof
KR102107825B1 (en) 2019-12-09 2020-05-07 주식회사 네이처센스 농업회사법인 Method for dissolving silk fibroin and it's hydrolyzate
KR102107818B1 (en) 2019-10-22 2020-05-07 주식회사 네이처센스 농업회사법인 Silk solubilization method for producing silk peptide for improving memory and cognitive function and method for producing hydrolyzate thereof
KR102107835B1 (en) 2019-12-05 2020-05-07 주식회사 네이처센스 농업회사법인 Method for dissolving silk fibroin and it's hydrolyzate
KR102107824B1 (en) 2019-10-25 2020-05-07 주식회사 네이처센스 농업회사법인 Solubilized composition of silk fibroin for food and solubilized silk fibroin for silk peptide preparation
KR102107823B1 (en) 2019-10-28 2020-05-26 주식회사 네이처센스 농업회사법인 Silk solubilizing composition and solubilized silk protein
KR102107822B1 (en) 2019-12-05 2020-05-28 주식회사 네이처센스 농업회사법인 Silk fibroin solubilized pretreatment composition and solubilized silk fibroin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115624566B (en) * 2022-12-22 2023-03-10 广东省人民医院 Peritoneal dialysis solution and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009005669A (en) * 2007-06-29 2009-01-15 Kyushu Univ Immobilized enzyme nanofiber, method for producing the same and reaction apparatus using the nanofiber
WO2011019211A2 (en) * 2009-08-12 2011-02-17 서울대학교 산학협력단 Silk nanofiber nerve conduit and method for producing thereof
JP2014205051A (en) * 2009-09-08 2014-10-30 フレゼニウス メディカル ケア ホールディングス インコーポレイテッド Peritoneal dialysis system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013241713A (en) * 2012-05-22 2013-12-05 Shinshu Univ Silk composite nanofiber and method for producing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009005669A (en) * 2007-06-29 2009-01-15 Kyushu Univ Immobilized enzyme nanofiber, method for producing the same and reaction apparatus using the nanofiber
WO2011019211A2 (en) * 2009-08-12 2011-02-17 서울대학교 산학협력단 Silk nanofiber nerve conduit and method for producing thereof
JP2014205051A (en) * 2009-09-08 2014-10-30 フレゼニウス メディカル ケア ホールディングス インコーポレイテッド Peritoneal dialysis system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHO, SE - YOUN ET AL.: "Controlling Pore Size of Electrospun Silk Fibroin Scaffold for Tissue Engineering", POLYMER( KOREA, vol. 36, no. 5, 2012, pages 651 - 655, XP055317570 *
LEE, MIN YEONG: "Preparation and Application of Medical Membrane using Silk Fibroin", MASTER'S THESIS OF KUMOH NATIONAL UNIVERSITY, 2014 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109385710A (en) * 2018-09-12 2019-02-26 浙江星月生物科技股份有限公司 A kind of absorbable suture and preparation method thereof
CN109337892A (en) * 2018-11-27 2019-02-15 贺州学院 The method of the fixed taro polyphenol oxidase of fibroin
CN109337892B (en) * 2018-11-27 2021-11-19 贺州学院 Method for immobilizing taro polyphenol oxidase by using fibroin
KR102107818B1 (en) 2019-10-22 2020-05-07 주식회사 네이처센스 농업회사법인 Silk solubilization method for producing silk peptide for improving memory and cognitive function and method for producing hydrolyzate thereof
KR102107824B1 (en) 2019-10-25 2020-05-07 주식회사 네이처센스 농업회사법인 Solubilized composition of silk fibroin for food and solubilized silk fibroin for silk peptide preparation
KR102107823B1 (en) 2019-10-28 2020-05-26 주식회사 네이처센스 농업회사법인 Silk solubilizing composition and solubilized silk protein
KR102107835B1 (en) 2019-12-05 2020-05-07 주식회사 네이처센스 농업회사법인 Method for dissolving silk fibroin and it's hydrolyzate
KR102107822B1 (en) 2019-12-05 2020-05-28 주식회사 네이처센스 농업회사법인 Silk fibroin solubilized pretreatment composition and solubilized silk fibroin
KR102107825B1 (en) 2019-12-09 2020-05-07 주식회사 네이처센스 농업회사법인 Method for dissolving silk fibroin and it's hydrolyzate

Also Published As

Publication number Publication date
KR101634205B1 (en) 2016-06-28

Similar Documents

Publication Publication Date Title
WO2016159500A1 (en) Filter for portable peritoneal dialysate regeneration system using enzyme-included silk fibroin and method for manufacturing same
EP1886704B1 (en) Adsorbent and column for extracorporeal circulation
CN106178161B (en) Method for removing cytokines from blood using surface immobilized polysaccharides
EP0488095B1 (en) High efficiency removal of low density lipoprotein-cholesterol from whole blood
US5187010A (en) Membrane having high affinity for low density lipoprotein-cholesterol from whole blood
EP0408462A2 (en) Filter material for seizure of leukocytes and method for production thereof
US5418061A (en) Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol
CA2095423A1 (en) High efficiency removal of low density lipoprotein-cholesterol from whole blood
CN101703893A (en) Hollow fiber ultrafiltration composite membrane, preparation method and application thereof
CN1177620C (en) Leukocyte-removing filter material
TW201842966A (en) Porous fiber and adsorption column
JP4983070B2 (en) Adsorbent and extracorporeal circulation column
JP3172542B2 (en) Filter material for capturing leukocytes and method for producing the same
CN112871139B (en) Whole blood perfusion adsorbent, preparation method and application thereof
JP4997770B2 (en) Adsorber
JP5017996B2 (en) Leukocyte and cytokine adsorber
JP2006288571A (en) Adsorbent for cancer treatment and column for extracorporeal circulation
US11596722B2 (en) Flow capture device and method for removing cells from blood
CN112203758A (en) Carrier for adsorbing organic substances
KR100978169B1 (en) Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer
JP3933300B2 (en) Polysulfone selective separation membrane
EP0570232A2 (en) Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol
JP7459449B2 (en) Adsorption material for soluble tumor necrosis factor receptors
JP4200689B2 (en) Extracorporeal circulation column for cancer treatment
JP2844758B2 (en) Hollow fiber type plasma separation membrane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16773281

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16773281

Country of ref document: EP

Kind code of ref document: A1